United States flag

Sr. Director, Clinical Development




Board certified MD preferred with focus in Oncology/Hematology

Experience Expected:

  • A minimum of 6 – 10 years’ Oncology clinical development experience leading high-complexity cross-functional drug development strategies and plans preferably in the biopharma industry.
  • Typically has multiple years’ line management (direct reports) experience.
  • Extensive experience interacting with and presenting to executives and managing large-scale budgets and other resources.
  • Demonstrated excellence leading large and complex teams in life sciences.

Functional Knowledge, Business Acumen and Problem Solving:

  • Has an expert-level of knowledge of the biopharma industry, as evidenced by proven track record in setting short and long-range development strategies and plans.   
  • Applies comprehensive understanding of procedures and practices within own discipline and emerging knowledge of related disciplines to resolve issues.
  • Integrates technical / functional expertise with business / commercial knowledge through participation and coordination across cross-functional groups.
  • Directs the resolution of highly complex or unusual business problems by applying advanced analytical thought and judgment.
  • Coaches experienced team members in resolving problems

Project Involvement         

  • Typically leads all components of projects for assigned products and/or indications.  Typically assigned larger and complex products. 


  • Typically reports to Executive Director or above.
  • May have multiple direct reports.
  • May be a standing member of the disease area Clinical Development Leadership Team.
  • Provides matrix management and leadership to project teams across a portfolio of projects for our largest and most complex molecules.
  • Independently creates and manages own budget and resource plans that may span the work across multiple Clinical Development team members. 

Scope and Strategic Influence:

  • Leads highly complex assignments that significantly influence the short- and long-range direction of drug development for our largest, most complex molecules.
  • Routinely represents Clinical Development to leadership teams and/or steering committees and advises on short- and long-range clinical development strategies, key decision-points, trade-offs and risks that significantly influence the direction of our highest profile products.


  • Impact at this level affects whether drug development strategies and milestones are achieved for a molecule or existing product that contributes significant potential revenue or existing revenue within our portfolio.  

Collaboration and Partnerships:

  • Represents the assigned molecule as needed in health authority interactions.
  • Develops thought leader and other external relationships that can guide short- and long-range clinical development strategies and direction for assigned molecules.
  • Routinely interacts with and advises cross-functional executives in and outside of Development.